Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892758 · ClinicalTrials.gov registry record
Replication of the P04334 Asthma Trial in Healthcare Claims Data
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 10,288
- Enrollment target
NCT04892758: Completed study, sponsored by Brigham and Women's Hospital.
NCT04892758 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 10,288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04892758 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 10,288 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Interventions
- DRUG Formoterol fumarate 10 mcg
- DRUG Mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,288 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2021-06-11 |
What the finished NCT04892758 record still lists
NCT04892758 is an observational study that tracks outcomes without assigning an intervention. Its 10,288 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Formoterol fumarate 10 mcg is the first listed.
NCT04892758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04892758 about?
NCT04892758 is a clinical study titled "Replication of the P04334 Asthma Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04892758?
This trial is currently completed. The enrollment target is 10,288 participants. The study started on 2020-10-29. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT04892758?
The interventions under investigation include: Formoterol fumarate 10 mcg (DRUG), Mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID (DRUG).
Who is sponsoring clinical trial NCT04892758?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07157774 · 10,450 participants · Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- NCT04332783 · 10,120 participants · NA
Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI